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Hypoxia stimulates proximal tubular cell matrix production via a
TGF-1-independent mechanism
CHRYSTALLA ORPHANIDES, LEON G. FINE, and JILL T. NORMAN
Department of Medicine, University College London Medical School, London, England, United Kingdom
Hypoxia stimulates proximal tubular cell matrix production via a
TGF-131.independent mechanism. Tubulointerstitial fibrosis is character-
ized by tubular basement membrane thickening and accumulation of
interstitial extracellular matrix (ECM). Since chronic low-grade hypoxia
has been implicated in the pathogenesis of fibrosis and proximal tubular
epithelial cells (PTE) are sensitive to oxygen deprivation, we hypothesized
that hypoxia may stimulate ECM accumulation. In human PTE, hypoxia
(1% °2, 24 hr) increased total collagen production (15%), decreased
MMP-2 activity (55% 13%; control = 100%) and increased tissue
inhibitor of metalloproteinase-1 (TIMP-1) protein. Collagen IV mRNA
levels decreased while collagen I mRNA increased, suggesting induction
of interstitial collagen. Hypoxia-induced changes persisted on re-oxygen-
ation with increased expression of TIMP mRNAs. A potential mediator
for these effects is transforming growth factor-fl1 (TGF-f31), a major
pro-fibrogenic factor produced by PTE. Although hypoxia stimulated
TGF-13 production (2- to 3-fold), neutralizing anti-TGF-/31 antibody did
not abolish the hypoxia-induced changes in gelatinase activity, TIMP-l,
collagen IV or collagen I mRNA expression, implying that TGF-f31 is not
the mediator. Furthermore, exogenous TGF-f31 (0 to 10 ng/ml) did not
mimic hypoxia, as it stimulated MMP-2 activity and increased the expres-
sion of collagen IV, collagen I and TIMP-1 mRNA. The data suggest that
hypoxia may be an important pro-fibrogenic stimulus independent of
TGF-f31.
Progressive renal disease, characterized by accumulation of
extracellular matrix (ECM) and expansion of the tubulointerstitial
compartment, represents a significant clinical problem culminat-
ing in renal failure [1]. The mechanisms underlying the initiation
and progression of fibrosis have not been identified. Among many
pathogenetic mechanisms [2], we have suggested that primary
injury to the proximal tubular cells (PTE) may lead to autocrine
and paracrine changes in ECM metabolism and to alterations in
interactions with adjacent cells (fibroblasts, capillary endothelia
and infiltrating inflammatory cells), resulting in thickening of the
tubular basement membrane (TBM) and the accumulation of
matrix material within the interstitium [31. One common patho-
logical injury preceding the development of fibrosis is hypoxia
[4—6]. Tubular cells may be subjected to low grade ischemia
secondary to hypertensive injury to the microvasculature. Also, as
ECM accumulates, physical separation of tubules and capillaries
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may reduce 02 delivery and impair function. Further, P°2 levels
in the tubulo-interstitium (TI) are lower than systemic values
rendering the TI relatively hypoxic, the increased metabolic
activity of PTE attendant on increased filtered protein in the
diseased kidney in combination with reduced 02 availability may
lead to ischemia of the tubular epithelia. Sensitivity of PTE to
hypoxia [2, 7—9] is illustrated by isolated tubule models of
ischemia/reperfusion in which oxygen deprivation leads to im-
paired protein synthesis [10], altered membrane transport [11, 12]
and loss in cell polarity [13], suggesting these cells as the primary
target for hypoxic injury. Expression of a number of genes have
been shown to be altered by reduced oxygen [14, 15] and in
different cell types, exposure to low oxygen tension induces
expression of a variety of growth factors and cytokines [14—16],
including several fibrogenic factors such as TGF-j3 [14, 17], PDGF
[7] and endothelin-1 [18, 19]. Hypoxia can directly regulate the
expression of these genes via oxygen-responsive DNA sequences,
as first described in the regulation of the erythropoetin (EPO)
gene [20, 21].
In addition to regulating cytokine gene expression, hypoxia is
known to regulate matrix production in a number of cell systems
[22—24], and although there are limited data available on the
effects of hypoxia on matrix synthesis in the kidney, an increase in
collagen gene expression has been demonstrated in mesangial
cells under hypoxic conditions [25]. ECM accumulation occurs as
a result of increased synthesis and/or decreased degradation [26],
however, the effects of hypoxia on the degradative aspect of
matrix metabolism have not been studied. ECM degradation is
regulated by the matrix metalloproteinases (MMP5), a family of
zinc-containing proteases that includes MMP-2 (gelatinase-A),
MMP-9 (gelatinase-B), collagenases and stromelysins [27, 281.
MMP activity is regulated by tissue inhibitors of metalloprotein-
ases (TIMPs), a family of four inhibitors [29]. Previous studies
from our group have shown that PTE produce MMP-2 and
MMP-9 together with TIMP-1 and -2, and it is known that in
fibrosis levels of MMP are either suppressed or unchanged while
inhibitor levels are often increased [26, 30, 31]. Given that hypoxia
may be a common component of renal fibrosis and a stimulus for
increased matrix production in some cell types, we wished to
establish whether hypoxia, either directly or indirectly, alters
matrix turnover in renal PTE, thereby initiating events that lead to
the fibrotic phenotype.
This study demonstrates that hypoxia simultaneously stimulates
collagen production in PTE while decreasing the activities of
MMP-2 and MMP-9 and increasing the expression of TIMPs,
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effects which appear to be largely independent of TGF-/31. In
addition to affecting tubular cell function, changes in matrix
composition and turnover in vivo could alter paracrine interac-
tions with neighboring fibroblasts, thereby initiating the cascade of
events leading to fibrosis. Hypoxia-induced alterations in matrix
metabolism may be common to diverse forms of organ fibrosis in
which there is microvascular compromise and decreased tissue
oxygen delivery.
METHODS
Cell culture
Human proximal tubular epithelial cells (PTE) were derived
from the histologically normal pole of kidneys removed for
carcinoma. Tissue was minced, passed through a 180 jxm sieve
(BDH Merck Ltd, Lutterworth, Leics, UK) to remove the gb-
meruli, plated on collagen I-coated tissue culture plastic (Greiner
Labs, Dursley, Glos, UK) and grown in RPMI 1640 medium
supplemented with 10% fetal calf serum (FCS), adenosine,
guanosine, uridine, cytosine (12.5 mg/ml each), transferrin (5
xg/ml), insulin (5 jxg/ml), dexamethasone (5 x jo M), antibiot-
ic/antimycotic (penicillin (100 U/mI), streptomycin (100 jxg/ml),
amphotericin B (25 ng/ml), HEPES (10 mM) (all reagents from
Sigma Chemical Company, Poole, Dorset, UK except RPMI 1640
and FCS, which were purchased from Gibco-BRL, Paisley, Scot-
land, UK). Cellular outgrowths from the tissue fragments ap-
peared 3 to 4 days after plating. Cells had a cobblestone morphol-
ogy characteristic of epithelial cells, and cellular identity was
confirmed by alkaline phosphatase activity and immunocytochem-
istry. The medium was changed every 3 to 4 days and cells were
passaged at confluence using trypsin-EDTA (tlypsin 0.5 mglml,
EDTA 0.2 mg/mI; Gibco-BRL). Cells were used for experiments
between passages I to 6. Confluent cells were made quiescent by
24 hour incubation in serum-free RPMI 1640 medium containing
nucleosides, HEPES, transferrin and antibiotic/antimycotic (qui-
escence media).
Cell characterization
Assay for alkaline phosphatase activity. Alkaline phosphatase
activity was measured using 5-bromo-4-chloro-3-indolyl-phos-
phate (BCIP) and 4-nitro blue tetrazolium chloride (NBT) as
described previously [32].
Immunocytochemistty. Cells at passage 2 (P2) were plated onto
collagen I-coated 8-well chamber slides (Gibco-BRL), grown to
semi-confluence (approximately 80% cover) and made quiescent.
Cells were fixed with ice-cold methanol at —20°C and stained as
described by Lewis, Fine and Norman [32] using the following
primary antibodies diluted in 2% bovine serum albumin (BSA) in
PBS: monoclonal anti-cytokeratin (CAM 5.2, 1:100 dilution;
Becton Dickinson Cowley, Oxford, UK), monoclonal anti-vimen-
tin (clone Vim 3B4, 1:250; Boehringer Mannheim), monoclonal
anti-a-smooth muscle actin (1:1000; Sigma), monocbonal anti-
desmin (1:1000; Sigma). Positive staining was detected using
biotinylated secondary antibodies (Vectastain Elite ABC Kit,
Vector Labs, Bretton, Peterborough, UK) followed by avidin-
biotin complex (ABC). Positive reactivity was visualized using the
chromogenic substrate aminoethylcarbazole (AEC-Substrate Kit,
Vector Labs) giving a red-brown precipitate. Cells were counter-
stained with Harris' hematoxylin (Sigma) for 30 seconds at room
temperature, rinsed in running water, mounted in Aqua-Poly-
mount (Polysciences Ltd, Molton Park, Northants, UK) and
examined on a Zeiss Axiophot microscope (Carl Zeiss
(Oberkochen) Ltd, Weiwyn Garden City, Herts, UK).
Hypoxic conditions
PTE were made quiescent for 24 hours as described above.
Fresh quiescence medium was added and cells incubated in 1%
02, 5% C02, 94% N2 in a Billups-Rothenberg Chamber°' (ICN-
Flow, High Wycombe, Bucks, UK) for 24 hours. The oxygen
concentration inside the chamber was confirmed at the end of the
hypoxic period using a Radiometer ABL4 (Radiometer, Copen-
hagen, Denmark). The media was replaced with fresh quiescence
media and the cells transferred to normoxia (21% 02) for 24
hours (referred to as 'post-hypoxia'). Conditioned medium (CM)
was collected at the end of hypoxia and at the end of the
post-hypoxia period. Media were clarified by centrifugation at
1,000 >< g for 15 minutes at 4°C and stored at —80°C prior to use.
Total protein content was measured using a modified Bradford
assay [32] on a DU-64 Spectrophotometer using the Soft-Pac'°
Protein Assay Module (Beckman Instruments Ltd., High Wy-
combe, Bucks, UK). Protein concentration was determined by
comparison to BSA standards (0 to 20 jxglml) prepared in
quiescence medium.
Measurement of cell viability
Cell viability was measured using both Tiypan Blue and LDH
release. For the Tiypan Blue assay, aliquots of cell suspension
were mixed with Trypan Blue (Sigma) in a 1:1 ratio and the
number of dead cells (uptake of blue dye) were calculated as a
percentage of the total cell number counted with a hemocytom-
eter (Marathon Laboratory Supplies, London, UK). LDH release
(as a percentage of total LDH) was measured using an LDH
Assay Kit (Sigma) according to the manufacturer's instructions.
Measurement of cell number and cell proliferation
Confluent, quiescent PTE were incubated in 2 xCi/ml ii-
thymidine (3H-TdR; 26Ci/mmol; Amersham International plc,
Little Chalfont, Bucks, UK) for two hours prior to harvest. Cells
were washed with PBS and TCA-precipitable material was solu-
bilized with 0.5 M NaOH. Radioactivity was counted in a Packard
2000CA Tri-Carb Liquid Scintillation Analyser (Canberra Pack-
ard, Pangbourne, Berks, UK) and calculated as disintegrations
per minute (dpm) per well. Cell number was counted using a
hemocytometer (Marathon).
Collagen production
Total collagen production was measured by reverse phase
HPLC (System Gold, Beckman Instruments Ltd) [331. Briefly,
PTE were grown in 12-well plates (6 replicate wells/treatment) in
RPMI 1640 media containing all supplements. At confluence,
cells were transferred to incubation media [RPMI 1640 containing
nucleosides, HEPES, transferrin, antihiotic/antimycotic, 23 jxg/rnl
proline (BDE-I Merck) and 50 xg/ml ascorbate (Sigma)] for 24
hours. Fresh incubation medium was added to the cells prior to
hypoxia (or exposure to control conditions). Cells were harvested
after 24 hours hypoxia or after a further 24 hours post-hypoxia
and the plates stored at —20°C prior to analysis. For HPLC, plates
were thawed, the cell layer scraped into the media and the
contents of each well collected. Wells were washed with PBS and
the rinse solution added to the cell suspension. Proteins were
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precipitated by addition of ethanol (to a final concentration of
67%). The samples were filtered through a 0.4 xm filter (type HV;
Millipore, Watford, UK) and the filter plus proteins hydrolyzed in
6 M HC1 at 110°C for 16 hours. The hydroxyproline content of the
hydrolysates was assessed after separation of the 7-chloro-4-
nitrobenz-2-oxa-1,3-diazole (NBD-Ci) derivatives of the imino
acid from other amino acid derivatives by HPLC. Quantitation
was achieved by measuring the peak area absorbance and com-
paring it to known standards of hydroxyproline run on the same
day. Procollagen production was expressed as nM OH-proline/
well.
Plates used for HPLC analysis of hydroxyproline were also used
to quantify non-collagen protein synthesis by measurement of
3H-phenylalanine (26 Ci/mmol; Amersham) in the hydrolysates.
Wells were labeled with 5 j.tCi/ml 3H-phenylalanine at the begin-
fling of the 24 hours of hypoxia (for 24 hr) or immediately before
the 24-hour post-hypoxia period (for 24 hr). Cells were processed
as for HPLC and radioactivity was measured in aliquots of
hydrolysate. Data are presented as dpm/weII.
RNA extraction and Northern blot analysis
Total cellular RNA was extracted using TRIZOLR Reagent
(Gibco-BRL) according to the manufacturer's instructions. The
concentration of RNA was measured by absorbance at 260 nm
and samples were stored at —80°C prior to use. For Northern blot
analysis, 10 jig of total RNA were electrophoresed on a 1.2%
agarose (ICN Flow) gel, containing 1.85% formaldehyde using ix
MOPS pH 7.0 (20 ms't MOPS (3-[N-morpholino]propanesulfonic
acid), 5 mi sodium acetate, 1 mivi EDTA) 3.7% formaldehyde as
the running buffer. Ethidium-bromide-stained gels were photo-
graphed under UV illumination. RNA was capillary blotted to
nitrocellulose membrane (Schleicher & Schuell, Dassel, Ger-
many) for 16 to 18 hours with I M ammonium acetate as the
transfer buffer and blots baked under vacuum at 80°C for two
hours. Membranes were prehybridized overnight at 65°C in 4 X
SSC (0.6 M NaC1, 60 mrvi Na3citrate2H2O), 5>< Denhardt's
solution [4 mg/mI polyvinylpyrrolidone (PVP), 4 mg/ml BSA, 4
mg/mi Ficoll; Sigma Chemical Company] 0.5% SDS, 5 mrvt Tris, 1
mM EDTA in a Techne Hybridization Oven (Techne Ltd, Dux-
ford, Cambs, UK). Blots were hybridized overnight at 65°C in
prehybridization solution containing 50 jig/mI pA-RNA (Boehr-
inger Mannheim), 50 jig/mI denatured salmon sperm DNA
(Sigma) and i0 dpm of a32P-dCTP-laheled cDNA probe. Blots
were washed 4 times, 20 minutes each, in 4 X SSC, 0.5% SDS at
50°C and exposed to autoradiography film (Kodak XAR; KJP,
London, UK) at —80°C with intensifying screens for 1 to 6 days.
Photographs of ethidium bromide-stained gels and autoradio-
grams were scanned and quantified by densitometry (ImageMas-
ter Software; Pharmacia, St Albans, Herts, UK). Values were
corrected for variations in RNA loading by comparison to densi-
tometry values of ethidium bromide-staining of rRNA normalizedt couj1, Data are expressed as relative mRNA levels calculated
as a percentage of the relevant control value (assigned a value of
100%) from arbitrary densitometry units.
Probes
eDNA probes for human MMP-2, TIMP-1 and TIMP-2 were a
generous gift from Dr. G. Murphy (Strangeways Laboratory,
Cambridge, UK). eDNA for collagen al(l) (HF677) was obtained
from Dr. ML. Chu (Thomas Jefferson University, Philadelphia,
PA, USA) and eDNA for human collagen al(IV) (HT-21) from
Dr. D. Prockop (Institute of Molecular Medicine, Allegheny
Hospital, Philadelphia, PA, USA). Probes were labeled with
cs32P-dCTP (3000Ci/mmol; Amersham) using a Random Primed
DNA Labeling Kit (Boehringer Mannheim) according to the
manufacturer's instructions.
MMP-2 and MMP-9 (gelatinases) activity
Gelatinase activity in CM was measured by gelatin-substrate gel
zymography [321. Protein concentration of conditioned media was
measured using a modified Bradford assay [32] and equal
amounts of protein were loaded following concentration with
Microcon-3 (Amicon Ltd, Stone House, Glos, UK) with a molec-
ular weight cut off at 3 kDa. Zymography was performed as
described by Lewis et a! [32]. Gels were scanned and bands
quantified by densitometry (ImageMaster Software; Pharmacia).
Relative MMP-2 activity was calculated as a percentage of the
relevant control value (assigned the value of 100%) from arbitrary
densitometry units.
ELISA for TIMP-1
TIMP-1 protein in conditioned media was measured using the
Biotrak Human TIMP-1 EL1SA System (Amersham) according to
the manufacturer's instructions. Briefly, 100 1.d aliquots of stan-
dards (0 to 50 ng/ml TIMP-1) or conditioned media samples
[diluted 1:5 in assay buffer (Amersham)] were incubated in
96-well plates pre-coated with anti-TIMP-1 antibody. Bound
TIMP-1 was detected using a peroxidase-labeled anti-TIMP-1
antibody that produces a blue color reaction on addition of the
substrate 3,3' 5,5'-tetramethylbenzidine (TMB). The addition of 1
M H2S04 produced a yellow color change, absorbance was read at
450 nm using a Multiskan MCC/340 plate reader (Titertek,
Labsystems, Finland). The concentration of TIMP-l in CM was
determined from the standard curve.
Bioassay for TGF-13
The mink lung epithelial cell line (CCL64; ECACC, Salisbury,
Wilts, UK) bioassay [34] was used to measure levels of latent!
active TGF-f3 (all isoforms) in PTE-CM. CCL64 are growth
inhibited by TGF-/3, hence the degree of 3H-TdR incorporation in
response to TGF-p1 standards can be used to quantify TGF-j3 (all
isoforms) in CM, Latent TGF-f3, produced by PTE, was activated
by heating CM samples at 80°C for 10 minutes prior to addition to
CCL64. Briefly, CCL64 were seeded at a density of 5 X 103/well
in Dulbecco's Modified Eagle Medium F12 (DMEM/F12, 1:1
mixture; Gibco-BRL) containing l0%FCS and incubated for 24
hours, the serum level was then reduced to 1% for a further 24
hours. Conditioned media (equal volume to existing media) was
added to each well for 24 hours and the cells labeled with 1
jiCi/well of 3H-TdR (Amersham) for five hours. Protein and DNA
were then precipitated, solubilized and assayed as in the prolifer-
ation assay. Concentrations of TGF-j3 in CM were measured by
comparison to a standard curve of exogenously added TGF-1 (0 to
10 ug/mI; Genzyme Diagnostics, West MaIling, Kent, UK) prepared
in serum-free RPMI media. Data are expressed as nglml acfive and
total TGF-/3 in CM from PTE exposed to 24 hours hypoxia or at 24
hours post-hypoxia with respect to the relevant controls.
Effect of exogenous TGF-131 on PTE
TGF-f31 (2.5 ng/ml or 10 ng/ml; Genzyme Diagnostics) was
added to cells under normoxic conditions for 24 hours. mRNA
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levels of MMP-2, TIMP-1, collagen I and collagen IV were
measured by Northern blot analysis and quantified by densitom-
etry as described above. To investigate the effect of exogenous
TGF-131 on MMP-2 activity, confluent, quiescent PTE were
treated with 0 to 10 ng/ml TGF-f31 for 24 hours under normoxic
conditions. CM was collected, clarified and analyzed by gelatin-
substrate gel zymography. Zymograms were scanned and quanti-
fied by densitometry as described above. Data are expressed as
relative MMP-2 activity calculated as a percentage of the relevant
control (assigned the value of 100%) from arbitrary densitometry
units.
Neutralization of TGF-p1 activity
To determine whether the effects of hypoxia on PTE are
mediated by TGF-j31, anti-TGF-f31 antibody (chicken IgY, 1.2
or 10 gIml; R&D Systems Europe Ltd, Abingdon, Oxon,
UK) was added to cells immediately before hypoxia and at the
beginning of the post-hypoxia period. Parallel experiments were
undertaken with non-immune chicken IgG (Sigma) added at the
same concentrations as the neutralising TGF-/3 antibody to exam-
ine the specificity of the blocking effect. The efficacy of the
antibody was tested by simultaneous addition of antibody and
exogenous TGF-131 (10 ng/ml; Genzyme Diagnostics) to PTE
under normoxic conditions. MMP-2 activity was assessed by
quantitation of gelatin-substrate gel zymography as above and
relative MMP-2 activity calculated as a percentage of the relevant
control (assigned a value of 100%) from arbitrary densitometry
units). Levels of mRNA expression of MMP-2, TIMP-1, collagen
I and collagen IV were measured by Northern blot analysis and
quantitated as described above.
Statistical analysis
Data were analyzed using Student's t-test (paired or unpaired,
as appropriate). Values are held to be significantly different when
the probability of such differences arising, assuming the null
hypothesis to be true, are less than 5% (P < 0.05). Where mean
values were calculated, standard errors of the mean are also given.
RESULTS
Characterization of human PTE
Cellular outgrowth from attached cortical tissue explants gen-
erally had a cobblestone appearance characteristic of epithelial
cells. Cells were positive for alkaline phosphatase (> 90%)
suggesting that cultures were composed predominantly of PTE
[32]. By immunocytochemistry, cells were positive for cytokeratin
(an epithelial cytoskeletal protein) but negative for vimentin (a
marker of cells of mesodermal origin), a-smooth muscle actin and
desmin (markers characteristsic of myofibroblasts and mesangial
cells). Taken together, these data confirmed the outgrowing cell
population to be predominantly epithelial. For experiments, cells
were used up to passage 6, as immunocytochemistry of cells at
higher passage numbers showed some positive staining for vimen-
tin, suggesting a possible dc-differentiation with repeated passag-
ing in vitro.
Effects of hypoxia on viability and cell proliferation
Cells were examined after 24 hours hypoxia and 24 hours
post-hypoxia for qualitative changes. Hypoxia had no effect on cell
morphology. There was no significant difference in cell number
Control Hypoxia Control Post-
hypoxia
Fig. 1. 3H-thymidine incorporation of PTE exposed to 24 hours of
hypoxia and 24 hours post-hypoxia. Confluent, quiescent cells were
labeled with 2 Ci/ml of 3H-TdR for two hours prior to harvest after 24
hours normoxia (Control), 24 hours hypoxia (Hypoxia), 48 hours nor-
moxia (Control), and 24 hours post-hypoxia (Post Hypoxia). 3H-TdR
incorporation is expressed as disintegrations per mm/well (dpm/well).
Data are the mean ( 5EM) of 3 experiments with N = 6 wells in each
sample/experiment.
per 10 cm2 dish (control, 3.27 X 106 0.35 X 106 cells vs. hypoxia,
3.30 X 106 0.46 X 106) or in cell viability as measured by Trypan
Blue-exclusion (number of control cells stained blue, 1.55 X iO'
0.10 x io vs. hypoxic cells, 1.41 X iO 0.12 X 10k). Measure-
ment of LDH released into the media calculated as a percentage
of total LDH confirmed that hypoxia had no effect on cell viability
(control, 44.9% 2.2% vs. hypoxia, 45.5% 0.8%). Further-
more, 3H-TdR incorporation showed that there was no effect on
cell proliferation either at the end of hypoxia or after the
post-hypoxia period (Fig. 1). These data suggest that exposure to
1% 02 for 24 hours does not cause macroscopic injury or cell
death, but cells showed increased attachment to the substrate with
treated cells requiring more prolonged trypsinization at passage.
Effect of hypoxia on collagen production and gene expression
Collagen production was measured by HPLC of cellular and
secreted hydroxyproline. Cells plus media were collected after 24
hours hypoxia and at 24 hours post-hypoxia. Hydroxyproline levels
were increased after hypoxia (Fig. 2A) and continued to increase
post-hypoxia with respect to the relevant control, achieving sta-
tistical significance 24 hours post-hypoxia (P < 0.05). To establish
whether this effect was specific for collagen, 3H-phenylalanine
incorporation into total protein was examined. As shown in Fig.
2B, total protein synthesis was decreased after 24 hours of hypoxia
and remained suppressed in the post-hypoxia period, indicating
that the stimulatory effect of hypoxia on collagen production may
be selective for specific proteins.
Northern blot analysis was performed to establish whether
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mRNA expression of PTE after 24 hours hypoxia and 24 hours post-
hypoxia. Total RNA was extracted from PTE exposed to: 24 hours
normoxia 21% 02 (Control); 24 hours hypoxia 1% 02 (Hypoxia); 48 hours
normoxia (Control); 24 hours post-hypoxia (Post Hypoxia). Autoradio-
grams were scanned and quantified by densitometry. Values were cor-
rected for variations in RNA loading by comparison to densitometry
values of ethidium bromide staining of rRNA. Relative mRNA levels were
calculated as a percentage of the relevant control values [assigned 100%
values (Eli)]. The data presented are a representative experiment of 3
repeats.
decreased, rather than increased, after 24 hours of hypoxia (46%
of control) and remained suppressed post-hypoxia. In contrast,
expression of mRNA for the interstitial collagen, collagen I, was
stimulated by hypoxia. PTE expressed low levels of collagen I
mRNA that increased by 48% after 24 hours of hypoxia and
remained elevated post-hypoxia (Fig. 3).
Effect of hypoxia on gelatinase gene expression and activity
Fig. 2. A. Collagen production by PTE exposed to 24 hours of hypoxia or
24 hours post-hypoxia. Hydroxyproline levels in confluent and quiescent
PTE exposed to 24 hours of normoxia (21% °2, Control), 24 hours of
hypoxia (1% °2, Hypoxia), 48 hours of normoxia (Control), and 24 hours
post-hypoxia (Post-hypoxia) were measured by HPLC analysis of cells plus
media. Concentrations of sample hydroxyproline were calculated from a
HPLC standard: 1 HPLC unit = 1 nm hydroxyproline. Data are the mean
of 2 experiments SEM, N = 6 wells in each sample/experiment. *P < 0.05
by unpaired Student's f-test. (B) 3H-phenylalanine incorporation of PTE
exposed to 24 hours hypoxia or in the period post-hypoxia. PTE used for
HPLC were labeled with: 3H-phenylalanine 24 hours normoxia, 21% 02
(Control); 24 hours hypoxia, 1% 02 (Hypoxia); 48 hours normoxia
(Control); 24 hours post-hypoxia (Post Hypoxia). Data are the mean of 2
experiments with N = 6 wells in each sample, < 0.05 by unpaired
Student's t-test.
increased collagen production was due to increased gene expres-
sion. Collagen type IV is the major constituent of the PTE
basement membrane, however, collagen IV mRNA levels (Fig. 3)
Gelatin-substrate gel zymography generally revealed two major
bands of activity in CM from PTE maintained in normoxia for 24
hours; one band at —72 kDa representing MMP-2 (gelatinase A)
and another at —92 kDa representing MMP-9 (gelatinase B).
Both bands often appeared as a doublet, the upper band indicat-
ing the inactive enzyme produced by the cells while the lower band
represented the active enzyme produced by proteolytic cleavage
of the inactive precursor. MMP-2 was observed in all PTE-CM
while the appearance of MMP-9 was more variable. After 24
hours of hypoxia, there was a significant decrease in MMP-2
activity (55% 13% of control value, assigned 100%; Fig. 4A),
which remained suppressed on return to normoxia for 24 hours
(65% 13.4% of the respective control). The decrease in MMP-2
activity on treatment with hypoxia is independent of passage
number with a variable decrease observed at all passage numbers.
MMP-9 showed a similar pattern of activity (data not shown).
Northern blot analysis demonstrated that MMP-2 mRNA levels
were not affected by hypoxia (Fig. 4B), suggesting that the
decrease in MMP-2 activity may be the result of post-transcrip-
tional regulation.
Effect of hypoxia on TIMP mRNA and protein
To evaluate hypoxia-induced changes in enzyme inhibitors,
TIMP-1 and TIMP-2 expression was examined. Northern blot
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Fig. 4. A. Gelatin-substrate gel zymography of the effect of hypoxia on
MMP-2 in PTE. Conditioned media was collected from confluent, quies-
cent PTE exposed to 24 hours normoxia, 21% 02 (Control); 24 hours
hypoxia, 1% 02 (Hypoxia); 48 hours normoxia (Control); 24 hours
post-hypoxia (Post Hypoxia). CM was concentrated and equal protein
electrophoresed per lane. Gels were scanned and quantified by densitom-
etry and relative MMP-2 activity was calculated as a percentage of the
relevant control values (assigned values of 100%) from arbitrary densi-
tometry units. Data are the mean of 3 experiments. Results were analyzed
by unpaired Student's t-test, P < 0.05. Insert: Photograph of a represen-
tative zymogram with lane order as in the graph. (B) Northern blot
analysis of MMP-2 mRNA expression of PTE after 24 hours of hypoxia
and 24 hours post-hypoxia. Total RNA was extracted from PTE exposed
to: 24 hours normoxia 21% 02 (Control); 24 hours hypoxia 1% °2
(Hypoxia); 48 hours normoxia (Control); 24 hours hypoxia post-hypoxia
(Post Hypoxia). Autoradiograms were scanned and quantified by densi-
tometry. Values were corrected for variations in RNA loading by com-
parison to densitometry values of ethidium bromide staining of rRNA.
Relative mRNA levels were calculated as a percentage of the relevant
control values (assigned values of 100%) from arbitrary densitometry
units. Data shown are a representative experiment of 3 repeats.
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TGF-f31 is the major fibrogenic cytokine within the kidney and
is induced by hypoxia in a variety of cell types. Expression of
TGF-p by PTE was examined using the mink lung epithelial cell
line CCL64 bioassay to measure active and total TGF-/3 (all
isoforms) in PTE-CM [35]. CCL64 cells are growth inhibited by
TGF-p such that the degree of 3H-TdR incorporation in response
to known concentrations of exogenous TGF-131 can be compared
with inhibition by conditioned media samples. Hypoxia induced a
160% increase in the amount of active TGF-13: 1 0.09 ng/ml in
control versus 2.6 0.18 nglml after 24 hours of hypoxia (Fig.
6A). Levels of total TGF-p in CM (active and latent) were also
increased following hypoxia: 9.5 0.92 nglml versus 3.0 0.47
nglml in control cultures (Fig. 6B). Assay of CM from cells in the
24-hour post-hypoxia period showed a decrease in both active
TGF-/3 (1.2 0.09 ng/ml vs. 4,0 0.2 nglml in control) and total
TGF-3 (6.5 0.41 ng/ml vs. 8.0 0.82 nglml in control).
Effect of exogenous TGF-fi1 on MMP-2 mRNA and activity,
TIMP-1, collagen I and collagen P/ mRNA expression
Since TGF-J31 is known to regulate matrix synthesis and turn-
over in a number of cell types [27], experiments were undertaken
to establish the effect of this factor on matrix metabolism. PTE
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Fig. 5. Northern blot analysis of TIMP-1 () and TIMP-2 (ll) mRNA.
Total RNA was extracted from PTE exposed to 24 hours normoxia 21%
02 (Control); 24 hours hypoxia 1% °2 (Hypoxia); 48 hours normoxia
(Control); 24 hours post-hypoxia (Post Hypoxia). Autoradiograms were
Control Post- scanned and quantified by densitometry. Values were corrected for
hypoxia variations in RNA loading by comparison to densitonietric values of
ethidium bromide-stained rRNA. Relative mRNA levels were calculated
as a percentage of the relevant control values (E, assigned the values of
100%) from arbitrary densitometry units. Data are a representative
experiment of 2 to 3 repeats.
analysis of TIMP-1 mRNA levels showed this to be similar in
24-hour control and hypoxia-treated cultures, with some increase
in the post-hypoxia period (Fig. 5). In contrast, TIMP-2 mRNA
levels decreased by approximately 35% of control after 24 hours
of hypoxia but then rose above the control value in the post-
hypoxia period (Fig. 5). Secreted TIMP-1 protein levels in
PTE-CM (measured by ELISA) increased after 24 hours hypoxia
(20% above control; data not shown).
Effect of hypoxia on expression of TGF-13 by PTE
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were treated with 0 to 10 ng/ml TGF-j31 under normoxic condi-
tions for 24 hours, cells were harvested for RNA and CM
collected for zymography. MMP-2 activity increased in response
to TGF-/31 in a dose-dependent manner (Fig. 7A). To examine the
effect of exogenous TGF-/31 on mRNA expression of MMP-2,
TIMP-l, collagen I and collagen IV, two concentrations of
TGF-/31 were tested: (1) 2.6 ng/ml, equivalent to the concentra-
tion of active cytokine produced by hypoxia-induced PTE as
calculated from the bioassay data (Fig. 6); and (2) 10 ng/ml,
equivalent to total TGF-j3 produced by PTE in hypoxia (Fig. 6).
By Northern blotting, TGF-J31 (2.5 ng/ml) stimulated MMP-2,
TIMP-1, collagen I and collagen IV mRNA levels (data not
shown). Addition of exogenous TGF-f31 at 10 ng/ml further
stimulated expression of all mRNAs (Fig. 7B), demonstrating a
dose-dependent effect of TGF-p1.
Effects of anti-TGF-fl antibody on PTE response to hypoxia
To establish whether the hypoxia-induced effects are mediated
by TGF-/31, PTE were exposed to hypoxia in the presence of two
concentrations of neutralising anti-TGF-p1 antibody: 1.2 jg/ml,
sufficient antibody to block all of the active TGF-f3 produced by
the cells after 24 hours hypoxia (2.6 ng/ml, calculated from TGF-J3
bioassay data; Fig. 6); and 10 xg/ml, sufficient to neutralize total
TGF-/3 produced by PTE under hypoxic conditions (active plus
latent, 9.5 ng/ml; Fig. 6). In PTE treated with TGF-f31 (10 ng/ml),
1.2 pg/mI anti-TGF-/31 antibody blocked the TGF-/31-induced
increase in MMP-2 activity (by 27%), MMP-2 mRNA (by 80%)
collagen IV mRNA (by 48%), collagen I mRNA (by 56%) and
TIMP-1 mRNA (by 62%). The higher concentration of antibody
completely blocked MMP-2 activity and further decreased
MMP-2 and collagen-I mRNA expression. The specificity of the
antibody was confirmed by the addition of non-immune IgG at
concentrations equivalent to the neutralizing antibody; non-im-
mune IgG had no effect on TGF-p-induced increases in MMP-2
expression and collagen I mRNA levels. Although the anti-
TGF-j3, antibody had some small effect, neither concentration
eliminated the hypoxia-induced decrease in MMP-2 activity (Fig.
8) or the increase in collagen I mRNA expression (Fig. 9) and
collagen IV, MMP-2 or TIMP-l mRNA levels (data not shown).
The control IgG had no effect on hypoxia-induced changes.
DISCUSSION
The mechanisms underlying the initiation and progression of
fibrosis have not been identified [35]. Since fibrotic renal diseases
of diverse etiology are commonly associated with vascular com-
promise [4—6], we hypothesized that tissue hypoxia, either alone
or in conjunction with other factors, may be a pro-fibrogenic
stimulus [6]. Although all cellular components of the tubulo-
interstitium (tubular epithelial cells, capillary endothelia and
interstitial fibroblasts) are likely to be affected by decreased
oxygen availability, the metabolic functions of PTE confer high
oxygen demands [36, 37], rendering these cells particularly vul-
nerable to fluctuations in oxygen levels in vivo [2, 7—10] and
leading to the suggestion that tubular cells may be the primary
target of a hypoxic insult [3], setting in train a cascade of autocrine
and/or paracrine changes that culminate in the accumulation of
ECM within the tubulo-interstitium.
The period of hypoxia used in this study (24 hr, 1% 02)was
based on data showing that in vitro exposure of various cell lines
to 1% 02 for a minimum of 16 hours alters growth factor gene
expression [14]. In PTE, 24 hours hypoxia had no macroscopic
effects on cell morphology, attachment or viability, although there
was some decrease in total protein synthesis consistent with the
findings of other groups that hypoxia impairs PTE protein syn-
thesis [10]. Of interest is the observation that PTE exposed to
hypoxia adhered more strongly to the substrate, perhaps reflecting
hypoxia-induced changes in expression of integrins and/or cell
adhesion molecules as has been reported in other cell types [38,
391. Although previous studies in our laboratory reported that 48
hours of hypoxia (1% 02) stimulated PTE proliferation [40],
which may be important in tubular regeneration after injury, the
shorter period of hypoxia used here had no effect on proliferation,
suggesting that the proliferative response may be secondary, due,
for example, to the induction of a mitogenic growth factor
[14—17].
In the normal kidney, the TBM, composed predominantly of
collagens IV and V, laminins, nidogen, fibronectin, heparan
sulphate proteoglycans and glycoproteins [41], separates epithelial
cells from neighboring cell types [42] and is essential for cell
12.5
10
C0
. 7.5
C
'3)0
00
1j 2.50
I—
0
Control Hypoxia Control Post- Control Hypoxia Control Post-
hypoxia hypoxia
Fig. 6. Effect of hypoxia on levels of (A) active
and (B) total TGF.fi in PTE-CM. TGF-j3 in
CM from PTE were measured using the CCL64
bioassay: CM from control cells maintained for
24 hours in normoxia (Control); CM from
control cells maintained for 24 hours in hypoxia
(Hypoxia); CM collected from cells exposed to
normoxia for 48 hours (Control); CM from
PTE exposed to 24 hours post-hypoxia (Post
Hypoxia). TGF-13 concentrations in CM
(sample number, N = 6 wells) were calculated
from a TGF-p1 standard curve (not shown).
Data shown is a representative experiment of 3
repeats where all results were significant, *P <
0.05, unpaired Student's t-test.
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production which increased further on return to normoxia. This
increase in total collagen production occurred despite an overall
decrease in protein synthesis, suggesting differential effects of
hypoxia on collagen and non-collagen proteins. Since collagen IV
is the major collagen component of the TBM [41, 43], it was of
interest to determine whether increased collagen production was
due to an increase in collagen IV. Surprisingly, collagen IV
mRNA levels decreased after hypoxia and remained suppressed
even after restitution of normal oxygen concentrations. In con-
trast, mRNA for the interstitial collagen, collagen I, was markedly
increased by hypoxia and remained elevated on return to nor-
moxia, suggesting that increased collagen prodution was due to
the induction of interstitial rather than BM collagen. A similar
increase in expression of collagen I accompanied by decreased
collagen IV levels has been reported in in vivo models of fibrosis
[2, 35]. Since matrix proteins themselves act as regulators of cell
growth, differentiation and function [441 the presence of atypical
collagen within the BM will likely have profound effects on
tubular cell behavior affecting both autocrine and paracrine
functions. The increase in collagens type I and III in the fibrotic
interstitium is largely attributed to interstitial fibroblasts; how-
ever, the increased expression of interstitial collagens by PTE
raises the possibility that, in addition to expansion of the TBM,
PTE may also contribute to interstitial matrix accumulation. In
addition, hypoxia has been reported to affect the processing of
collagen producing a weaker molecule [23]. It is interesting to
speculate that similar changes in the TBM, which provides
structural support for the tubular cells, might contribute to
tubular collapse observed in the advanced fibrosis [11.
On the other side of the balance, the major physiological
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Fig. 8. Effect of anti-TGF-j31 antibody on MMP-2 activity in PTE exposed
to 24 hours hypoxia. CM was collected from PTE exposed to 24 hours
normoxia (Control); 24 hours hypoxia (Hypoxia) or 24 hours hypoxia in
the presence of anti-TGF-/31 antibody (Hypoxia + anti-TGF-j31). Gelatin-
gel zymography was performed and quantified by densitometry. Relative
MMP-2 activities were calculated as a percentage of the control value
(assigned the value of 100%). Data shown are the mean of 4 experi-
ments SEM.
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Fig. 7. A. Effect of exogenous TGF-13 on MMP-2 activity in normoxic
PTE. Confluent, quiescent PTE were treated with 0 to 10 ng/ml TGF-131
for 24 hours. Gelatin-gel zymography was performed on conditioned
media and MMP-2 activity quantified by densitometry (arbitrary units).
The Figure shows a representative experiment of 3 repeats. (B) Northern
blot analysis of MMP-2, TIMP-1, collagen I and collagen IV mRNA levels
in normoxic PTE treated with exogenous TGF-1. RNA was extracted
from confluent, quiescent PTE maintained in: normoxia for 24 hours
(Control); normoxia for 24 hours in the presence of exogenous TGF-/31
(10 nglml; +TGF-1). Autoradiograms were scanned and quantitated as
above. Relative mRNA levels were calculated as a percentage of the
control value (assigned the value of 100%) from arbitrary densitometry
units. The data show a representative experiment of 3 repeats.
function and interactions [32, 41]. The normal matrix is main-
tained by a balance between synthesis and turnover. In fibrosis,
increased matrix synthesis and/or decreased degradation, leads to
thickening of the TBM and the appearance of abnormal matrix
proteins [1, 35]. The mediators of changes in ECM metabolism in
fibrosis have not been identified, hut hypoxia has been reported to
stimulate matrix synthesis in other cell systems with increased
expression of csl-procollagen, tropoclastin and fihronectin
mRNAs [22—24]. Although the effects of hypoxia on ECM syn-
thesis have not been extensively studied in the kidney, increased
collagen gene expression has been reported in hypoxic mesangial
cells [25]. Hypoxia (24 hr) markedly increased PTE collagen
+ anti- + Non-immune
TGF-j3 IgG
I I
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Table 1. Comparison of the effects of hypoxia and TGF-p1
0
Control Hypoxia
Fig. 9. Effect of anti-TGF-/31 antibody on collagen I mRNA in PTE
exposed to 24 hours of hypoxia compared to the addition of non-immume
serum IgG. Total RNA was extracted from PTE exposed to: 24 hours of
normoxia 21% 02 (Control); 24 hours hypoxia 1% 02 (Hypoxia); nor-
moxia or hypoxia in the presence of 1.2 J.Lg/ml anti-TGF-/31 (+ anti-TGF-
/3); exposed to normoxia or hypoxia in the presence of 1.2 xg!ml
non-immune serum IgG (+ non-immune serum IgO). Autoradiograms
were scanned and quantitated as above. Relative mRNA levels were
calculated as a percentage of the control value (assigned the value of
100%) from arbitrary densitometry units. The data show a representative
experiment.
regulators of matrix turnover are the MMPs, with enzyme activity
controlled by the TIMPs [27—29]. Renal cells express a variety of
MMPs and TIMPs [26, 451 and changes in enzymes and/or
inhibitor levels have been reported in a number of models of
fibrosis and in human disease [30, 31, 46, 47], suggesting an
important role for decreased degradation in the accumulation of
ECM. Gelatinases are likely to be involved in BM turnover as
their primaiy substrate is collagen IV, a major constituent of the
BM [41, 43]. The data presented here demonstrate that, in vitro,
hypoxia suppresses activity of both MMP-2 and MMP-9 in PTE
cells by 45% and that this decrease is sustained when cells are
returned to normoxia, a situation analogous to ischemia/reperfu-
sion injury (although the decrease is not exacerbated as might be
expected in reperfusion injury). Regulation of MMP-2 activity
appears to be post-transcriptional since mRNA levels were not
affected by hypoxia. Hypoxia-induced increases in mRNA stability
have been reported in other systems [48], however, increased
stability would be reflected in increased steady-state levels. Thus
the data in PTE point to translational or post-translational
regulation of enzyme activity. Although gelatinases can be inhib-
ited by any of the TIMPs, the inhibitor most widely studied in the
kidney is TIMP-1 [30, 31], which is expressed by normal PTE and
interstitial fibroblasts [26, 36, 37, 47]. TIMP-2 is also expressed,
albeit at lower levels (unpublished observations). In this study,
secreted TIMP-1 was increased after 24 hours of hypoxia, but
there was no change in mRNA expression suggesting post-
transcriptional regulation of the inhibitor in this period. TIMP-2
mRNA levels were transiently suppressed after hypoxia, but both
TIMP-1 and TIMP-2 mRNA levels increased on return to nor-
moxia, implying a delayed increase in these inhibitors. These data
suggest that hypoxia decreases PTE matrix degradation via
Hypoxia TGF-f31
Collagen production I ND
Collagen I mRNA 1' 1'
Collagen IV mRNA . I
MMP-2 mRNA NC
activity I I
TIMP-1 mRNA (I) I
protein I ND
TIMP-2 mRNA I ND
Abbreviations are: NC, no change; ND, no data.
changes in enzyme activity and inhibitor levels and, simulta-
neously, increases collagen production. Similar effects of de-
creased oxygen in vivo would lead to an accumulation of matrix
and have repercussions on tubular cell function and on interac-
tions between PTE and adjacent cell types (capillary endothelia
and interstitial fibroblasts).
In vivo, the damage to PTE caused by a brief ischemic episode
is relatively small compared to the injury inflicted when normal
blood flow is resumed [91. Some parallels can be drawn in the
current in vitro model where hypoxia-induced changes in matrix
synthesis and turnover were maintained or exacerbated on return
to normoxia. Relatively short periods of post-hypoxia were stud-
ied and it is not clear whether enzyme, inhibitor and ECM protein
levels would, with time, return to control or if the changes induced
represent long-term alterations, possibly regulated by an auto-
crine mechanism(s), and leading to a chronic accumulation of
ECM material. Net collagen production did continue to increase
up to 72 hours post-hypoxia, suggesting long-term effects of a
single hypoxic incident. While a 24 hour period of 1% oxygen is
unlikely to have a direct in vivo parallel these studies demonstrate
the potential for hypoxia-induced changes in vivo. Further inves-
tigations will examine the effects of longer periods of less severe
hypoxia, in an attempt to mimic sustained chronic low grade
hypoxia in vivo and determine the effects of repeated hypoxic
insults to establish whether a single hypoxic episode renders the
cell more susceptible to a second hypoxic 'hit' resulting in
sustained injury.
It remains to be established whether the effects of hypoxia on
PTE ECM metabolism are mediated by direct effects on gene
expression via 02-responsive enhancer elements (ORE) present
in the gene promoters [141 or are mediated by secondary factors
(such as growth factors or cytokines) induced by hypoxia [14].
Hypoxia has been reported to stimulate the production of a
variety of growth factors including the pro-fibrotic factor, TGF-/3,
in a variety of cell types [50]. Three of the five isoforms of TGF-13
(TGF-/313) have been identified in mammalian cells [51] and
TGF-f31 has been implicated as a major fibrogenic agent in the
lung, liver and kidney [51—55]. PTE produce TGF-f3 (mainly
TGF-f3, with smaller amounts of TGF-132 [561) under normoxic
conditions, suggesting this growth factor as a candidate mediator
for the hypoxia-induced changes in ECM metabolism. Although
hypoxia stimulated secretion of both active and latent TGF-/3 by
PTE, the addition of the neutralizing anti-TGF-/31 antibody did
not block the hypoxia-induced decreases in gelatinolytic activity
and collagen IV mRNA levels or the increases in expression of
TIMP and collagen I mRNAs. Furthermore, exogenous TGF-/31
(at concentrations equivalent to active (2.6 ng/ml) and total
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kidneys in which narrowing of the glomerular vessels would lead
to reduced renal oxygenation [57]. In addition, it may be that the
genes of matrix proteins, such as the collagens, demonstrate
oxygen sensitivity, responding directly to changes in oxygen levels
via ORE [14].
In summary, this study demonstrates that hypoxia simulta-
neously stimulates PTE collagen production and decreases matrix
turnover via decreased gelatinase activity and increased expres-
sion of TIMPs. The mechanism(s) by which these changes occur
remain to be worked out but appear to be independent of
TGF-131. Hypoxia has differential effects on collagen gene expres-
sion, suppressing collagen IV and stimulating collagen I. Thus, the
increase in collagen production is due to increased expression of
collagen I, an isoform more commonly associated with interstitial
matrix rather than the TBM. Similar changes in matrix composi-
tion and turnover in vivo could alter both tubular cell function and
paracrine interactions with other cell types leading to ECM
accumulation. The data presented in this study support the
hypothesis that hypoxic injury to PTE may be a pro-fibrogenic
stimulus and may provide a common pathway by which diseases of
diverse etiology produce a similar pathology. The concept of
hypoxia as a modulator of matrix metabolism is clearly of impor-
tance in the kidney, but is also likely to be relevant in other organs
that undergo fibrosis such as the lung, liver and skin, where
ischemic injury to cpithelial cells precedes the development of
fibrosis.
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